Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Eltrombopag

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

56 API Suppliers, 22 USDMF, 4 JDMF, 7 EU WC, 4 KDMF, 16 NDC API, 36 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

62 Drugs in Development

62 Drugs in Development

INTERMEDIATES

17 Intermediate Suppliers

17 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

198 FDF Dossiers, 33 FDA Orange Book, 117 Europe, 4 Canada, 16 Australia, 2 South Africa, 26 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 12.5MG ACID, TABLET;ORAL - EQ 25MG ACID, TABLET;ORAL - EQ 50MG ACID, TABLET;ORAL - EQ 75MG ACID

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 14 SPI Pharma, 7 DKSH, 2 Pharm-RX Chemical, 1 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Kirsch Pharma, 1 ACG Worldwide, 2 Actylis, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 12 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 1 Clariant, 10 Corel Pharma Chem, 3 DFE Pharma, 10 Gangwal Chemicals, 5 Ideal Cures, 2 Ingredion Pharma Solutions, 13 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 14 Roquette, 12 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 22 Direct Compression, 22 Controlled & Modified Release, 20 Disintegrants & Superdisintegrants, 20 Thickeners and Stabilizers, 18 Solubilizers, 16 Granulation, 15 Chewable & Orodispersible Aids, 15 Taste Masking, 14 Parenteral, 12 Lubricants & Glidants, 10 Film Formers & Plasticizers, 10 Co-Processed Excipients, 9 Rheology Modifiers, 8 Topical, 6 API Stability Enhancers, 5 Empty Capsules, 5 Coloring Agents, 5 Emulsifying Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 27 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 11 Annual Reports

MARKET PLACE

13 APIs, 7 FDF Dossiers

PATENTS & EXCLUSIVITIES

101 US Patents, 13 US Exclusivities, 12 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP

2 USP

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
31/10/2025	Zhejiang Hengkang Pharmaceutical	China	ZHEJIANG HENGKANG PHARMACEUTICAL CO LTD	40357	ELTROMBOPAG OLAMINE	2024-11-25	Active	II	N/A
31/10/2025	Granules India Limited	India	GRANULES INDIA LTD	39129	ELTROMBOPAG OLAMINE	2023-12-31	Active	II	Complete	2024-02-13	2024-01-08

Eltrombopag

Eltrombopag

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

56 API Suppliers

22 USDMF

4 JDMF

7 EU WC

4 KDMF

16 NDC API

36 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

62 Drugs in Development

INTERMEDIATES

17 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

198 FDF Dossiers

33 FDA Orange Book

117 Europe

4 Canada

16 Australia

2 South Africa

26 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 12.5MG ACID

TABLET;ORAL - EQ 25MG ACID

TABLET;ORAL - EQ 50MG ACID

TABLET;ORAL - EQ 75MG ACID

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc

14 SPI Pharma

7 DKSH

2 Pharm-RX Chemical

1 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 Kirsch Pharma

1 ACG Worldwide

2 Actylis

1 Aeon Procare

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

12 BASF

1 Bioplus Life Sciences

1 CD Formulation

1 Clariant

10 Corel Pharma Chem

3 DFE Pharma

10 Gangwal Chemicals

5 Ideal Cures

2 Ingredion Pharma Solutions

13 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

11 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

3 Novo Excipients

3 Pharmatrans-Sanaq

4 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

14 Roquette

12 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

3 Silverline Chemicals

2 The Dow Chemical Company

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders

TABLET;ORAL - EQ 100MG ACID Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons